Literature DB >> 19216837

Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods.

J Hobart1, S Cano.   

Abstract

OBJECTIVES: In this monograph we examine the added value of new psychometric methods (Rasch measurement and Item Response Theory) over traditional psychometric approaches by comparing and contrasting their psychometric evaluations of existing sets of rating scale data. We have concentrated on Rasch measurement rather than Item Response Theory because we believe that it is the more advantageous method for health measurement from a conceptual, theoretical and practical perspective. Our intention is to provide an authoritative document that describes the principles of Rasch measurement and the practice of Rasch analysis in a clear, detailed, non-technical form that is accurate and accessible to clinicians and researchers in health measurement. REVIEW
METHODS: A comparison was undertaken of traditional and new psychometric methods in five large sets of rating scale data: (1) evaluation of the Rivermead Mobility Index (RMI) in data from 666 participants in the Cannabis in Multiple Sclerosis (CAMS) study; (2) evaluation of the Multiple Sclerosis Impact Scale (MSIS-29) in data from 1725 people with multiple sclerosis; (3) evaluation of test-retest reliability of MSIS-29 in data from 150 people with multiple sclerosis; (4) examination of the use of Rasch analysis to equate scales purporting to measure the same health construct in 585 people with multiple sclerosis; and (5) comparison of relative responsiveness of the Barthel Index and Functional Independence Measure in data from 1400 people undergoing neurorehabilitation.
RESULTS: Both Rasch measurement and Item Response Theory are conceptually and theoretically superior to traditional psychometric methods. Findings from each of the five studies show that Rasch analysis is empirically superior to traditional psychometric methods for evaluating rating scales, developing rating scales, analysing rating scale data, understanding and measuring stability and change, and understanding the health constructs we seek to quantify.
CONCLUSIONS: There is considerable added value in using Rasch analysis rather than traditional psychometric methods in health measurement. Future research directions include the need to reproduce our findings in a range of clinical populations, detailed head-to-head comparisons of Rasch analysis and Item Response Theory, and the application of Rasch analysis to clinical practice.

Entities:  

Mesh:

Year:  2009        PMID: 19216837     DOI: 10.3310/hta13120

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  139 in total

1.  Further validation of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) in the UK veterinary profession: Rasch analysis.

Authors:  David J Bartram; Julia M Sinclair; David S Baldwin
Journal:  Qual Life Res       Date:  2012-03-02       Impact factor: 4.147

2.  Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease.

Authors:  Stina Bladh; Maria H Nilsson; Gun-Marie Hariz; Albert Westergren; Jeremy Hobart; Peter Hagell
Journal:  J Neurol       Date:  2011-09-29       Impact factor: 4.849

3.  Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson's disease versus health care professionals: a concept mapping study.

Authors:  Catharina Sjödahl Hammarlund; Maria H Nilsson; Markus Idvall; Scott R Rosas; Peter Hagell
Journal:  Qual Life Res       Date:  2014-01-04       Impact factor: 4.147

4.  Rasch analysis of clinical outcome measures in spinal muscular atrophy.

Authors:  Stefan J Cano; Anna Mayhew; Allan M Glanzman; Kristin J Krosschell; Kathryn J Swoboda; Marion Main; Birgit F Steffensen; Carole Bérard; Françoise Girardot; Christine A M Payan; Eugenio Mercuri; Elena Mazzone; Bakri Elsheikh; Julaine Florence; Linda S Hynan; Susan T Iannaccone; Leslie L Nelson; Shree Pandya; Michael Rose; Charles Scott; Reza Sadjadi; Mackensie A Yore; Cynthia Joyce; John T Kissel
Journal:  Muscle Nerve       Date:  2013-07-26       Impact factor: 3.217

5.  Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force.

Authors:  John H Powers; Donald L Patrick; Marc K Walton; Patrick Marquis; Stefan Cano; Jeremy Hobart; Maria Isaac; Spiros Vamvakas; Ashley Slagle; Elizabeth Molsen; Laurie B Burke
Journal:  Value Health       Date:  2017-01-10       Impact factor: 5.725

6.  FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery.

Authors:  E H Lee; A F Klassen; S J Cano; K S Nehal; A L Pusic
Journal:  Br J Dermatol       Date:  2018-05-23       Impact factor: 9.302

7.  Is the Give Youth a Voice questionnaire an appropriate measure of teen-centred care in paediatric oncology: a Rasch measurement theory analysis.

Authors:  Anne F Klassen; Stefan J Cano; Roona Sinha; Areej Shahbaz; Robert Klaassen; David Dix
Journal:  Health Expect       Date:  2013-11-28       Impact factor: 3.377

8.  The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson's disease and healthy controls.

Authors:  Peter Hagell; Albert Westergren; Shorena Janelidze; Oskar Hansson
Journal:  Qual Life Res       Date:  2016-05-19       Impact factor: 4.147

9.  Uncovering indicators of the international classification of functioning, disability, and health from the 39-item Parkinson's disease questionnaire.

Authors:  Maria H Nilsson; Albert Westergren; Gunilla Carlsson; Peter Hagell
Journal:  Parkinsons Dis       Date:  2010-07-12

10.  Interpretation of response categories in patient-reported rating scales: a controlled study among people with Parkinson's disease.

Authors:  Ida Knutsson; Helena Rydström; Jan Reimer; Per Nyberg; Peter Hagell
Journal:  Health Qual Life Outcomes       Date:  2010-06-24       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.